2022 annual financial data
Niki BioSolutions 2022 Operating margin
Direct answer
Operating margin was -1,351.01%.
Operating income was -17,509,113 USD and net income was -9,800,000 USD.
Operating cash flow was -12,318,965 USD.
Get free Niki BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,296,000 USD
- Operating income
- -17,509,113 USD
- Net income
- -9,800,000 USD
- Operating cash flow
- -12,318,965 USD